Literature DB >> 2835881

The role of parainfluenza viruses in inspiratory difficulties in children.

M Korppi1, P Halonen, M Kleemola, K Launiala.   

Abstract

Viral findings were prospectively studied in middle and lower respiratory tract infections in 449 hospitalized children during a 12-month follow-up period. A viral aetiology was found in 30 of the 65 children (46%) with inspiratory difficulties. Parainfluenza viruses were the infective agents in 24 of the 30 cases with viral diagnoses (80%), type 2 being the most prominent. There were 38 cases of parainfluenza infections, type 2 being the infective agent in 58% of the 24 cases of parainfluenza infections with inspiratory difficulties but in only 21% of the 14 cases of parainfluenza infections without inspiratory difficulties. Type 2 parainfluenza virus produced inspiratory difficulties in 82% of the cases as opposed to 56 and 50% of the cases for type 1 and 3, respectively. It is concluded that the type 2 parainfluenza virus has a particular association with inspiratory difficulties in children. Viral diagnosis was reached using direct antigen detection in nasopharyngeal specimens by radioimmunoassay in 59% and using complement fixation serology in 76% of parainfluenza infections. Direct antigen detection was especially useful in infants. We suggest that direct antigen detection should be used as a primary virological diagnostic method in small children with middle and lower respiratory tract infections.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2835881     DOI: 10.1111/j.1651-2227.1988.tb10607.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  4 in total

1.  Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study.

Authors:  S Husby; L Agertoft; S Mortensen; S Pedersen
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

2.  Potential role of hands in the spread of respiratory viral infections: studies with human parainfluenza virus 3 and rhinovirus 14.

Authors:  S A Ansari; V S Springthorpe; S A Sattar; S Rivard; M Rahman
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

3.  Recombinant human parainfluenza virus type 2 vaccine candidates containing a 3' genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primates.

Authors:  Sheila M Nolan; Mario H Skiadopoulos; Konrad Bradley; Olivia S Kim; Stacia Bier; Emerito Amaro-Carambot; Sonja R Surman; Stephanie Davis; Marisa St Claire; Randy Elkins; Peter L Collins; Brian R Murphy; Anne Schaap-Nutt
Journal:  Vaccine       Date:  2007-07-03       Impact factor: 3.641

4.  Aetiology of community-acquired pneumonia in children treated in hospital.

Authors:  M Korppi; T Heiskanen-Kosma; E Jalonen; P Saikku; M Leinonen; P Halonen; P H Mäkela
Journal:  Eur J Pediatr       Date:  1993-01       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.